儿童疫苗接种计划时代常规儿童免疫接种的健康与经济收益——美国,1994-2023年
常规儿童免疫接种持续提供重大健康与经济收益,并促进健康公平。
要点
- 从支付方和社会角度均显示 substantial 成本节约。
核心结论
- 常规儿童免疫接种持续提供重大健康与经济收益,同时促进健康公平。
研究设计与样本
- 使用既定经济模型估计1994-2023年出生的30个年度队列儿童终身避免的疾病、死亡及相关成本。
- 纳入VFC合格与非合格儿童,评估九种疫苗。
主要发现
- 从支付方和社会角度均显示 substantial 成本节约。
关键数值与推荐
- 纳入疫苗:白喉破伤风类毒素和无细胞百日咳疫苗、b型流感嗜血杆菌结合疫苗、口服和灭活脊髓灰质炎病毒疫苗、麻疹腮腺炎风疹疫苗、乙型肝炎疫苗、水痘疫苗、肺炎球菌结合疫苗、甲型肝炎疫苗和轮状病毒疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since 1994, the U.S. Vaccines for Children (VFC) program has covered the cost of vaccines for children whose families might not otherwise be able to afford vaccines. This report assessed and quantified the health benefits and economic impact of routine U.S. childhood immunizations among both VFC-eligible and non-VFC-eligible children born during 1994-2023. Diphtheria and tetanus toxoids and acellular pertussis vaccine; Haemophilus influenzae type b conjugate vaccine; oral and inactivated poliovirus vaccines; measles, mumps, and rubella vaccine; hepatitis B vaccine; varicella vaccine; pneumococcal conjugate vaccine; hepatitis A vaccine; and rotavirus vaccine were included. Averted illnesses and deaths and associated costs over the lifetimes of 30 annual cohorts of children born during 1994-2023 were estimated using established economic models. Net savings were calculated from the payer and societal perspectives. Among approximately 117 million children born during 1994-2023, routine childhood vaccinations will have prevented approximately 508 million lifetime cases of illness, 32 million hospitalizations, and 1,129,000 deaths, at a net savings of $540 billion in direct costs and $2.7 trillion in societal costs. From both payer and societal perspectives, routine childhood vaccinations among children born during 1994-2023 resulted in substantial cost savings. Childhood immunizations continue to provide substantial health and economic benefits, while promoting health equity.
引用
- Zhou F, Jatlaoui TC, Leidner AJ, et al. Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39116024. doi:10.15585/mmwr.mm7331a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。